Comparison of renal safety and bone mineral density of tenofovir and entecavir in patients with chronic hepatitis B: a systematic review and meta-analysis
Objectives: Tenofovir disoproxil fumarate (TDF) and entecavir (ETV) are recommended as first-line treatments for chronic hepatitis B (CHB). However, the safety of these two drugs remains controversial. This study aimed to evaluate and compare renal function and bone mineral density in patients with...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2022-11-01
|
| Серія: | International Journal of Infectious Diseases |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S1201971222005197 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|